Personalized Medicine through Integration of Immune Phenotypes in Autoimmune Skin Disease (PerMIPA)

Overview

The PerMIPA (Personalized Medicine through Integration of Immune Phenotypes in Autoimmune Skin Disease) study is focused on understanding the immune system's role in autoimmune skin disorders.  This project aims to analyze and integrate immune phenotypes with clinical and genetic data from patients affected by conditions such as psoriasis, vitiligo, and lupus. By examining the variations in immune responses and their genetic underpinnings, the initiative seeks to uncover the mechanisms driving these autoimmune diseases with the goal of developing more effective, targeted treatments and improving patient care.

Principal Investigator

Michelle Kahlenberg, MD, PhD

Digital Health Innovation Support

Digital Health Innovation provided genetic data for this project.